MTHFR and Rare hereditary thrombophilia: Comparing the results from this study, it could be concluded that in healthy individuals the most frequent mutation is for MTHFR heterozigous, which is similar with the studies from other authors [17] but without thrombophilia were 56.7%, compared with the study of Kumferminc -80%.